Ordinary Reweighting | Solactive Europe & US Top Pharmaceuticals 2020 AR 3.5% Index | Effective Date 2nd October 2023
In the ordinary reweighting, the following composition will be implemented effective open 02.10.2023:
| ABBVIE INC |
| ASTRAZENECA PLC |
| BRISTOL-MYERS SQUIBB CO |
| JOHNSON & JOHNSON |
| MERCK & CO. INC. |
| NOVARTIS AG |
| NOVO NORDISK A/S |
| PFIZER INC |
| ROCHE HOLDING AG |
| SANOFI SA |